Lonza Group AG
SIX:LONN
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
325
587.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Lonza Group AG
Retained Earnings
Lonza Group AG
Retained Earnings Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Lonza Group AG
SIX:LONN
|
Retained Earnings
CHf9.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
15%
|
||
Bachem Holding AG
SIX:BANB
|
Retained Earnings
CHf717.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
14%
|
CAGR 10-Years
8%
|
||
Siegfried Holding AG
SIX:SFZN
|
Retained Earnings
CHf1.2B
|
CAGR 3-Years
24%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
||
Tecan Group AG
SIX:TECN
|
Retained Earnings
CHf1.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
||
PolyPeptide Group AG
SIX:PPGN
|
Retained Earnings
€166.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
||
SKAN Group AG
SIX:SKAN
|
Retained Earnings
CHf169m
|
CAGR 3-Years
64%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
Lonza Group AG
Glance View
Lonza Group AG is a Swiss multinational company that specializes in the life sciences and advanced materials industries, making it an integral player in the global biotechnology and pharmaceutical landscapes. Founded in 1897, Lonza has evolved from a traditional chemical manufacturer to a leading contract development and manufacturing organization (CDMO) that partners with clients to accelerate the development of innovative therapies. The company offers a wide range of services, including biopharmaceutical manufacturing, cell and gene therapy solutions, and specialized expertise in microbial products and industrial bioprocessing. As pharmaceutical companies continue to explore complex biologics, Lonza stands out for its extensive technological capabilities and state-of-the-art facilities, positioning itself at the forefront of an industry that is rapidly transforming healthcare. For investors seeking to understand Lonza's value proposition, it’s essential to appreciate the company's robust financial performance and strategic growth initiatives. Lonza has consistently demonstrated strong revenue growth, driven by its diversified portfolio and a commitment to research and development. The company has made significant investments in expanding its global manufacturing footprint, notably through the integration of advanced technology for efficient production processes. Furthermore, Lonza's strategic collaborations with major pharmaceutical enterprises in cell and gene therapies highlight its potential for sustained growth. As the world increasingly emphasizes innovation in the healthcare sector, Lonza Group AG remains well-poised to capitalize on emerging opportunities, making it an attractive prospect for investors looking to tap into the growing life sciences market.
See Also
What is Lonza Group AG's Retained Earnings?
Retained Earnings
9.5B
CHF
Based on the financial report for Jun 30, 2024, Lonza Group AG's Retained Earnings amounts to 9.5B CHF.
What is Lonza Group AG's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
15%
Over the last year, the Retained Earnings growth was 2%. The average annual Retained Earnings growth rates for Lonza Group AG have been 21% over the past three years , 22% over the past five years , and 15% over the past ten years .